MediSapiens Gets $ 1 Million for World’s First Personalized Cancer Medicine Software

HELSINKI, June 1, 2010 – MediSapiens, world's first software company for personalized
cancer medicine in oncology clinics and drug development, completed
$ 1 million (EUR 0.8 million) seed round investment from Veraventure, ETFIII
advised by Eqvitec Partners, VTT Ventures and Lifeline Ventures.

MediSapiens is based on scientific research at the VTT
Technical Research Centre of [...]

Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus

Acquisition Bolsters Pulmonary Portfolio and Capabilities, Accessing Promising Pipeline of First-in-Class Compounds and Renowned Team of Respiratory Scientists

HORSHAM, Pennsylvania, June 1, 2010 – Centocor Ortho Biotech Inc. today announced that it has acquired
RespiVert Ltd., a privately held drug discovery company focused on developing
small-molecule, inhaled therapies for the treatment of pulmonary diseases.
The company's lead compounds, [...]

Novartis Disappointed by Initial NICE Decision on Xolair(R) (omalizumab)[1] and Concerned that Children Suffering from Severe Persistent Allergic Asthma will be Denied Access to Treatment[1]

FRIMLEY, England, June 1, 2010 -

– Just for UK media, not for Ireland

– This release is intended for consumer media

– Add-On Omalizumab Reduces the Rate of Asthma Attacks in
Children Aged 6 to 11 Years With Severe [...]

Elsevier Foundation Invites 2010 Proposals for Innovative Libraries in Developing Countries Program

September 15th Deadline for Grants to Promote Research in the Developing World

NEW YORK, June 1, 2010 – The Elsevier Foundation is seeking new grant proposals for the 2010
Innovative Libraries in Developing Countries program. Sponsored by Elsevier,
a leading global publisher of scientific, technical and medical information,
the Innovative Libraries program provides grants to library programs in [...]

NanoPowers Raises CHF 5 Million ($4.5 Million) in Series A Financing to Support Development of Breakthrough Urinary Incontinence Device

LAUSANNE, Switzerland, June 1, 2010 – NanoPowers SA, a medical device company that leverages its unique
artificial muscle technology to restore or improve muscle function, today
announced the closing of a CHF 5 million ($4.5 million) series A financing.
The financing round was led by Novartis Venture Funds (NVF). Also
participating in the financing were Initiative Capital Romandie [...]

Oncolytics Biotech(R) Inc. Receives Approval From Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers

CALGARY, Canada, June 1, 2010 – Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today
announced that it has received approval from the Belgian Federal Agency for
Medicines and Health Products (FAMHP) to conduct its Phase 3 trial examining
REOLYSIN in combination with paclitaxel and carboplatin in patients with
platinum-refractory head and neck cancers. This is the same trial that [...]

Now You Can Teach an Old Dog New Tricks

LONDON, June 1, 2010 – Scientists have identified a range of nutrients which will
boost memory, learning capacity and ability to adapt to new situations among
elderly canine pets. Britain's six million dog owners will be able to benefit
from the anti-ageing compound which claims to improve brain activity in older
dogs.

Researchers have found [...]

Refurbished Medical Imaging Equipment – Growing Business During Lean Economy – Upcoming Frost & Sullivan Web Conference

LONDON, June 1, 2010 – In times of an economic downturn, the refurbished medical imaging
equipment market experiences a substantial upswing in comparison to the
turnover with new equipment. However, in different parts of Europe the demand
for refurbished medical imaging systems varies just as much as the pricing
dynamics across different tiers of vendors. While the development [...]

SynapDx Corporation Raises US$9 Million in Series A Funding

Company to Develop Proprietary Technologies for the Early Detection of Autism

WALTHAM, Massachusetts, June 1, 2010 – SynapDx Corp., a new company focused on developing and commercializing
diagnostic testing for the early detection of autism, announced the
completion of a US$9 million Series A financing by Bain Capital Ventures,
General Catalyst Partners, and North Bridge Venture Partners.
[...]

The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Issues Practice Guideline Addressing the Management of Gastroesophageal Reflux Disease and Barrett’s Esophagus

Endoscopic radiofrequency ablation deemed to have significant clinical utility in the treatment of patients with all clinical stages of Barrett's esophagus

SUNNYVALE, California, June 1, 2010 – BARRX Medical Inc., a leader in the development of minimally invasive
medical devices designed to remove precancerous tissue from within the
gastrointestinal tract, reported today that the Society of American
Gastrointestinal [...]

Listen Up to Avoid Hearing Aids Scams Across the UK

PETERBOROUGH, England, June 1, 2010 – One in seven people in the UK suffer from some degree of hearing loss; a
figure that rises to 40% for people aged 50 or over and a staggering 71% for
the over 70s. The only real solution for the vast majority of these people is
wearing a hearing aid (www.hearingaidsattrade.co.uk/).

[...]

Pharmacopeial Education Enhanced by Laboratory Training Improves Quality of Medicines in the Russian Federation

USAID-Funded, USP-Delivered Pharmacopeial Education Courses in Moscow
ROCKVILLE, Maryland, June 1, 2010 – Under the Memorandum of Understanding (MOU) signed by ROSZDRAVNADZOR and
the U.S. Pharmacopeial Convention (USP) in April of 2009 with the goals of
protecting and improving the quality of medicines, USP conducted specialized
courses in Moscow for the staff of laboratory facilities of the Federal
Districts [...]

Marlin Equity Partners Acquires Datafarm – Will Be Fully Merged with Liquent

HORSHAM, Pennsylvania, June 1, 2010 – Liquent, Inc. ("Liquent") is pleased to announce that Marlin Equity
Partners ("Marlin") has acquired Datafarm, Inc., a leading provider of
software and services solutions designed to support the regulatory business
processes of life sciences companies. In December 2009, Marlin acquired
Liquent from Thomson Reuters. Datafarm will be fully merged into Liquent.

[...]

The ‘We Can Face It’ Campaign Launched

Dr Dawn Harper, Mica Paris and Jason Gardiner Lead Launch of New Survey Report Showing Impact of Unwanted Facial Hair in Women

LONDON, June 2, 2010 – The We Can Face It campaign for women with unwanted facial hair (UFH) has
been launched today at a celebrity-backed event held at the Sunbeam Studios
in West London. Television [...]

Zimmer Highlights Advancements in Reconstructive and Trauma Offerings at 11th EFORT Congress in Madrid, Spain

Clinical Success and Product Innovations Headline Zimmer Presentation Schedule

MADRID, June 2, 2010 – Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal
care, today announced its presentation schedule for the 11th annual EFORT
(European Federation of National Associations of Orthopaedics and
Traumatology) Congress, highlighting advancements in its Reconstructive and
Trauma offerings. Zimmer will be presenting three [...]

Research Report on Chinese Health Service Industry, 2010-2011 Now Available on ReportsandReports

DALLAS, June 2, 2010 – ReportsandReports Announce it Will Carry Research Report on Chinese
Health Service Industry, 2010-2011
(www.reportsandreports.com/Report/23919/) Market Research Report in
its Store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/research-report-on-chinese-he
alth-service-industry-2010-2011/
Health service is not only a concept, but also a method, a complete and
thorough service procedure. It intends to help patients [...]

Concentric Medical Announces CE Mark of Aspiration Indication for the DAC(TM) Family of Neurovascular Catheters

MOUNTAIN VIEW, California, June 2, 2010 – Concentric Medical, Inc., the global leader in devices for clot removal
in ischemic stroke patients, today announced an important expanded indication
for the full line of DAC(TM) Neurovascular Catheters. CE Mark was granted
allowing the DAC family of distal access catheters to be used for the
removal/aspiration of fresh, soft emboli [...]

Zimmer Highlights Acetabular System Portfolio at the 11th EFORT Congress in Madrid, Spain

Proven Fixation Technology and Advanced Bearing Options Combine to Better Match Individual Patient Demands

MADRID, June 3, 2010 – Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal
care, will be showcasing its extended Acetabular Cup portfolio at this year's
EFORT (European Federation of National Associations of Orthopaedics and
Traumatology) Congress in Madrid, Spain. The recently [...]

Surrey Clinical Research Centre Achieves MHRA Accreditation

GUILDFORD, England, June 3, 2010 – The Medicines and Healthcare products Regulatory Agency (MHRA) has
awarded the Surrey Clinical Research Centre (Surrey CRC) at the University of
Surrey standard accreditation for conducting clinical pharmacology Phase I
trials -

tinyurl.com/2fmgt7t
The accreditation scheme was introduced to improve the safety of clinical
research volunteers [...]

INTUNIV(TM) – Shire Files Suit Against Anchen Pharmaceuticals, Inc. and Anchen, Inc.

DUBLIN and PHILADELPHIA, June 3, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its subsidiary Shire LLC has filed
a lawsuit in the U.S. District Court for the District of Delaware against
Anchen Pharmaceuticals, Inc. and Anchen, Inc. (collectively "Anchen") for the
infringement of U.S. Patent Nos. 5,854,290 (the '290 patent), [...]

Concentric Medical Announces 1,000th Patient Enrolled in the Merci Registry

MOUNTAIN VIEW, California, June 3, 2010 – Concentric Medical, Inc., the global leader in acute ischemic stroke
intervention, announced completion of enrollment in the Merci Registry with a
total of 1,000 patients enrolled. The Merci Registry is a real-world,
international, post-market study of the Merci Retrieval System(R). Since its
launch in June 2007, over 30 sites worldwide have [...]

Zimmer Partners With EFORT FOUNDATION on 2010 Visiting Fellowship Program

MADRID, June 3, 2010 – Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal
care, today announced a new partnership with the EFORT (European Federation
of National Associations of Orthopaedics and Traumatology) FOUNDATION to
further educational opportunities for young orthopaedic surgeons. Zimmer will
provide 120,000 euro to the EFORT FOUNDATION Visiting Fellowship Program,
which will award grants [...]

Phase III Study Results Showed Eisai’s Eribulin Mesylate Significantly Improved Overall Survival in Patients With Locally Recurrent or Metastatic Breast Cancer

Global EMBRACE Study Compared Eribulin to Treatment of Physician's Choice

CHICAGO, June 6, 2010 – Results of a Phase III study presented today at the American
Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's
eribulin mesylate significantly improved median overall survival (OS)
compared with Treatment of Physician's Choice (TPC) in heavily pre-treated
metastatic breast cancer patients.[1]
[...]

O2h to Provide Discovery Support to Karyopharm Therapeutics, Inc.

CAMBRIDGE, England, June 7, 2010 – O2h (Ahmedabad, India) is pleased to announce the signing of an
agreement with Karyopharm Therapeutics, Inc. (Newton, Massachusetts, USA)
under which O2h will provide Karyopharm discovery services to advance
Karyopharm's lead small molecule program toward the nomination of a
development candidate.

Dr. Sharon Shacham, co-founder and CSO of Karyopharm, [...]

Survey Reveals Many are Ignoring Basic Measures to Check for no.1 Heart Killer Disorder in Europe

On World Heart Rhythm Week, Arrhythmia Alliance Launches 'Know Your Pulse' Campaign to Raise Awareness of the Importance of Pulse Checking to Keep Cardiac Conditions Under Control

STRATFORD-UPON-AVON, England, June 7, 2010 – Arrhythmia Alliance, the Heart Rhythm Charity, announced today the
results of a survey conducted in Europe that showed a large number of
respondents ignore [...]

Fi Asia Philippines – A New Opportunity for the Regional Food Industry

BANGKOK, June 7, 2010 – The first Food Ingredients Asia show ever held in the Philippines will
give the domestic food industry greater access to much needed ingredients and
technology from around the world. The three day business-to-business event
will also be a banquet of opportunity for international food manufacturers
who will attend from all over the world. [...]

Isobionics Introduces Natural Valencene Pure(TM)

GELEEN, The Netherlands, June 7, 2010 – Isobionics has finalized the development of a breakthrough fermentation
process for production of its natural Valencene Pure(TM). This product, which
is an aroma substance for the food, beverage, flavor and fragrance industry,
is now available on a commercial scale. Compared with conventional valencene,
which is produced from oranges, it offers the [...]

Oncolytics Biotech(R) Inc. Collaborators Present Positive Updated U.K. Phase I/II Trial Results in Advanced Solid Cancers With a Focus on the Head and Neck at the ASCO Annual Meeting

CALGARY, Canada, June 7, 2010 – Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced
today that a poster presentation covering updated results of its Phase I/II
U.K. trial (REO 011) of REOLYSIN(R) combined with paclitaxel/carboplatin for
patients with advanced cancers was presented today at the ASCO 2010 Annual
Meeting in Chicago, IL.

The poster entitled "Phase [...]

First Phase III Trial With Definitive Results in Advanced Medullary Thyroid Cancer Shows Statistically Significant Extension of Progression Free Survival for Patients

LONDON, June 7, 2010 – Results from ZETA, a phase III study in
patients with advanced medullary thyroid cancer (MTC), showed that treatment
with the investigational drug vandetanib significantly extended Progression
Free Survival (PFS), the primary endpoint of the study, by demonstrating a
54% reduction in the rate of progression compared to placebo (HR=0.46,
p=0.0001). The results of the [...]

Chiltern Achieves Supplementary Accreditation From the Medicines and Healthcare Products Regulatory Agency

LONDON, June 7, 2010 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO), has announced that Chiltern Early Phase Limited, based in
Ninewells Hospital and Medical School in Dundee, Scotland, has achieved
Supplementary Accreditation from the Medicines and Healthcare products
Regulatory Agency (MHRA).

Dr Brian Sanderson, Medical Director, Chiltern Early Phase, explains, "In
November [...]

Health Robotics Announces i.v.STATION and i.v.SOFT Contract With Sandoz Canada (Novartis) and Sphynx

BOZEN, Sud-Tirol, Italy, June 7, 2010 – Health Robotics announced that its joint-venture Health Robotics Canada
Inc. (HRCI), Sandoz Canada Inc., and Sphynx Medical Inc. have all recently
signed a marketing agreement to expand into Canada the market presence of
i.v.STATION and i.v.SOFT, revolutionary technologies that provide automated
sterile compounding of intravenous medications and parenteral nutrition to
hospitals.

[...]

Vertellus Specialties Moves Forward With 3-Cyanopyridine and Vitamin B3 Production Expansion in Asia

INDIANAPOLIS, June 7, 2010 – Vertellus Specialties Inc. ("Vertellus" or the "Company") announced today
that it will break ground on a new 3-cyanopyridine production unit at
Vertellus' production facility in Nantong, Jiangsu, China. This unit is a
continuation of a larger effort to expand production capacity in Nantong. It
will increase Vertellus' Vitamin B3 manufacturing capacity in the [...]

Study Reveals Survival Benefit for Patients With Inoperable Hepatocellular Carcinoma (HCC) Treated With a Unique Combination of Radioactive Microspheres and Standard-of-Care Systemic Therapy

CHICAGO, June 7, 2010 – A unique combination of liver targeted radioactive microspheres
(SIR-Spheres) and a standard-of-care systemic agent (Sorafenib) appears to
confer a survival benefit for patients with inoperable primary hepatocellular
cancer (HCC) including those with disease that has spread outside the liver,
according to the results of a prospective clinical study presented today at
the 46th American [...]

Elsevier and InfoDesk Collaborate to Co-develop Federated Drug Pipeline Intelligence Solution

First Release to Integrate Comprehensive Drug Pipeline Data and Real-Time Intelligence From Multiple Content Sources in a Single Search

NEW YORK, June 7, 2010 – Elsevier, a world-leading healthcare and scientific publisher, announced
today that it has reached an agreement with Tarrytown, New York based
InfoDesk to co-develop a federated drug pipeline intelligence solution for
pharmaceutical and life [...]

Commercial Insight: Osteoporosis – Market Players Maximize Revenue Growth Before the Next Challenging Phase Report now Available on ReportsandReports

DALLAS, Texas, June 7, 2010 – ReportsandReports Announce it Will Carry the Commercial Insight
Osteoporosis Market Players Maximize Revenue Growth Before the Next
Challenging Phase Market Research Report (
www.reportsandreports.com/Report/24113/) in its Store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/commercial-insight-osteoporos
is-market-players-maximize-revenu/
(Due to the length of these URLs, it may be necessary to copy [...]

Clinical Diagnostics in India: Market Analyses and Participant Directory Report Now Available on ReportsandReports

DALLAS, June 7, 2010 – ReportsandReports Announces it Will Carry the Clinical Diagnostics in
India: Market Analyses and Participant Directory Market (
www.reportsandreports.com/Report/25249/) Research Report in its Store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/clinical-diagnostics-in-india
-market-analyses-and-participant-di/
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into [...]

Pieris AG Appoints Chief Scientific Officer

FREISING-WEIHENSTEPHAN, Germany, June 7, 2010 – Pieris AG announced today that Laurent Audoly, Ph.D., has joined the
company as Chief Scientific Officer, effective immediately. Dr. Audoly, most
recently Biologics Research Site Lead at Merck & Co. Inc., brings both pharma
and biotech experience, with extensive expertise in therapeutic protein drug
development.

"Laurent has an impressive [...]

Landmark Study Confirms GRAZAX(R) as the Only Grass Allergy Immunotherapy Tablet to Show Sustained Effect 2 Years After Treatment Completion

LONDON, June 7, 2010 – Data published at the European Allergy, Asthma & Clinical
Immunology (EAACI) congress in London today documents that GRAZAX(R) is the
only allergy immunotherapy tablet (AIT) to show sustained disease control 2
years after treatment completion. Leading specialists emphasise the relevance
of the data with regard to inclusion in guidelines for treatment of grass
pollen [...]

Melinda Gates Calls for Global Action to Save Women’s and Children’s Lives

Gates Foundation Commits US$1.5 Billion for Integrated Women's and Children's Health Programs

WASHINGTON, June 7, 2010 – Melinda Gates today urged global leaders to make women's and children's
health a top priority, and announced that the Gates Foundation will invest
US$1.5 billion over the next five years to support maternal and child health,
family planning, and nutrition programs [...]

Confused Britons Believe Injections are Main Option for Managing Type 2 Diabetes

New Tablet for Type 2 Diabetes Launched Today
LONDON, June 8, 2010 – When Britons think about type 2 diabetes, one of their greatest concerns
is potentially needing to inject themselves,1 as estimated by a new survey
released today. Despite tablets being available to help manage the condition,
nearly half (46 percent) of those surveyed still wrongly perceive [...]

Personal Health Records App Debuts on iPad

DETROIT, June 8, 2010 – Webahn, Inc. today announced that Capzule PHR, the first personal health
records App for iPad, is now available on the App Store. Capzule PHR is a
universal app that lets iPhone and iPod touch users install it as well.

Capzule PHR is also the first PHR on iPhone [...]

Binding Site Financial Results

Continued Strong Growth, 35% Rise in Freelite Sales
BIRMINGHAM, England, June 9, 2010 – The Binding Site Group, a specialist medical diagnostics group
developing, manufacturing and distributing diagnostic tests for a range of
cancers and immune disorders, today announced its results for 2008 to 2009.
The privately-owned UK-based business, whose products are used by clinicians
and laboratories worldwide, reported [...]

Misys Takes Decisive Steps to Realise Shareholder Value

LONDON, June 9, 2010 – In a video presentation on financial broadcaster www.cantos.com,
Misys CEO Mike Lawrie outlines plans to create a market leader in the US
healthcare IT industry through the proposed acquisition by Allscripts of
healthcare solutions company Eclipsys.

In addition, he announces the proposed disposal of the majority of
Misys's stake in [...]

Unique Hereditary Angioedema e-Learning Initiative Launched at 29th Congress of the European Academy of Allergy and Clinical Immunology

LONDON, June 9, 2010 – The HAE Awareness Programme was launched today, an online
interactive training programme aimed to increase awareness of Hereditary
Angioedema (HAE). Developed by an Editorial Board of HAE Experts and
supported by an unrestricted educational grant from CSL Behring Ltd,
www.hae-awareness.net was launched at the 29th Congress of the
European Academy of Allergy and Clinical [...]

Bladder Cancer – Poor Understanding Jeopardises Care

LONDON, June 9, 2010 – Bladder cancer: we don't mind talking about it, but over half of us have
no idea what causes it, according to a survey(1) from the new charity, Action
on Bladder Cancer (ABC) – www.actiononbladdercancer.org. The majority
(88%) of 2,055 people invited to participate in the survey were willing to do
so. Yet, over [...]

The Widespread Increase in PACS Installation to Spur Growth in the European Digital Radiography Market, Says Frost & Sullivan

LONDON, June 9, 2010 – Radiology has witnessed a technological evolution in the past few decades
with the development of innovative imaging modality. The emergence of (DR)
digital radiography and (CR) computed radiography has altered the face of
conventional radiography. With the economy recovering and capital becoming
available to potential buyers, the unit shipment volume is expected to [...]

Helsinn Healthcare S.A. and Eisai Inc. Extend Relationship

Enter U.S. Licence and Co-promotion Agreement for Potential New Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV)

LUGANO, Switzerland and WOODCLIFF LAKE, New Jersey, June 9, 2010 – Helsinn Healthcare S.A. and Eisai Inc. today announce the
signing of a licensing agreement granting Eisai Inc. commercialization rights
for a new product for potential use in [...]

MarketsandMarkets: BRIC Telemedicine Technology Market Worth US $418.4 Million by the Year 2014

DALLAS, June 9, 2010 – According to the new market research report, " BRIC Telemedicine Market"
published by MarketsandMarkets (www.marketsandmarkets.com), the BRIC
telemedicine is expected to reach a market size of $418.4 million by the year
2014, at a CAGR of 15.8% from 2009-2014. The BRIC telemedicine technology
market is expected to reach a size of $307.4 million [...]

Retail Banking Technology Spending Through 2014: Business Function Segmentation (Interactive Model) Report Now Available on ReportsandReports

DALLAS, June 9, 2010 – ReportsandReports announces it will carry the Retail Banking Technology
Spending Through 2014: Business Function Segmentation (Interactive Model)
Market (www.reportsandreports.com/Report/7225/) Research Report in its
Store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/retail-banking-technology-
spending-through-2014-business-functio/
Datamonitor's retail banking technology spending forecast model provides
a current and comprehensive assessment of revenue opportunities for
technology providers [...]

IntraLinks Enhances its SaaS-Based Safety Document Exchange Solution for the Life Sciences Industry

NEW YORK, June 9, 2010 – IntraLinks, a leading provider of critical information exchange
solutions, today announced an enhanced version of its SaaS-based Safety
Document Exchange, a scalable solution for safety teams that manage reporting
for Serious Adverse Events (SAEs) around the world. IntraLinks' Safety
Document Exchange enables users to save time and money related to SAE intake
and [...]

MarketsandMarkets Partners With Marcus Evans for Their PharmaMarketing Summit 2010

PharmaMarketing Summit 2010
DALLAS, June 9, 2010 – About the PharmaMarketing Summit

This unique forum offers much more than any conference,
exhibition or trade show. The PharmaMarketing Summit will bring together
esteemed industry thought leaders and solution providers to a highly focused
and interactive networking event. The summit includes Pharma marketing
presentations on social media, healthcare [...]

HealthFocus(R) Studies Reveal That Few Consumers in U.S. or UK Know How Much Sodium to Consume

CHICAGO, June 9, 2010 – A recent HealthFocus(R) International study revealed significant
confusion and concern among U.S. consumers regarding acceptable sodium levels
in the foods and beverages they regularly consume. While nearly two-thirds
(65%) of all consumers express some concern about sodium intake; 79% do not
know that the recommended daily intake is 1500-2400mg.

These [...]

FDA Agrees to UltraShape 510(k) Pathway

Expected to Shorten FDA Clearance Process
YOKNEAM, Israel, June 9, 2010 – UltraShape Ltd. announced today that the US Food and Drug
Administration advised the company that it may submit a request for clearance
of its Contour I system under the 510(k) regulation rather than as a
Pre-Market Approval (PMA) as was previously advised.

Proceeding [...]

Illicit Cigarette Trade Funds Terrorism and Organized Crime

KIEV, Ukraine, June 9, 2010 – There is clear and convincing evidence that large sums are being siphoned
from the multi-billion dollar revenues from the global cigarette smuggling
trade into the pockets of terrorist networks and international organized
crime.

A United Nations Security Council investigative body, the Group of
Experts, has reported that millions of [...]

PSI Board Member Ashley Judd Calls for Greater Investments in Women and Girls

Joins global leaders and advocates at the Women Deliver 2010 Conference to encourage action on maternal health, funding and human rights

WASHINGTON, June 8, 2010 – PSI Board Member and Global Ambassador Ashley Judd joined the Executive
Director of UNFPA, Thoraya Obaid, the former President of Chile Michelle
Bachelet, the former President of Ireland Mary Robinson, and [...]

Experts Call for Global Delivery of Proven Technologies to Stop Cervical Cancer in World’s Poorest Countries

Immediate Action to Prevent Cervical Cancer Deaths is Key to Achieving Women's Health Goals

WASHINGTON, June 8, 2010 – Women's health leaders today called on the international community to
commit the resources needed to ensure that women and girls worldwide have
equal access to cervical cancer prevention technologies. At the WOMEN DELIVER
conference, the Declaration for Universal Access [...]

The Leona M. and Harry B. Helmsley Charitable Trust Announces US$10 Million in Grants to Three Projects in Israel

NEW YORK, June 8, 2010 – The Leona M. and Harry B. Helmsley Charitable Trust today announced
grants totaling more than US$10.1 million to help fund three major projects
in Israel. The grants are as follows:

1. US$4,265,747 for the Tel Aviv Sourasky Medical Center in Tel Aviv, to
help patients avoid post-surgery complications [...]

PharmaMar Initiates a Phase III Registration Trial with Aplidin(R) in Multiple Myeloma Patients

MADRID, June 8, 2010 – PharmaMar SA (Grupo Zeltia, ZEL.MC) today announced that a registration
trial in relapsed/refractory multiple myeloma patients has been initiated
with Aplidin(R) (plitidepsin) in combination with dexamethasone versus
dexamethasone alone.

This pivotal, international, multicenter Phase III clinical trial, called
ADMYRE, will enrol 300 patients in 60 medical centers across 20 countries
(including [...]

Bioartificial Human Liver Therapy Trial Progressing

Vital Therapies Enrolls First Patients in Expansion of its U.S. Clinical Trial in Europe

SAN DIEGO, June 9, 2010 – Vital Therapies, Inc., (VTI) is pleased to announce that the first two
subjects have been enrolled at King's College Hospital in London in the
expansion of its SILVER (Stabilization In LiVER failure) clinical trial in
Europe. The trial [...]

Frost & Sullivan Lauds Sorrento Therapeutics for Making Strides in the Global Biopharmaceutical Market

LONDON, June 9, 2010 – Based on its recent research, Frost & Sullivan presents Sorrento
Therapeutics Inc. (Sorrento Therapeutics) with the 2010 Global
Biopharmaceutical Emerging Company of the Year Award. The human monoclonal
antibodies (mAbs) market is teeming with opportunities and was worth nearly
US$30 billion in 2009, growing at a healthy double digit rate of around 20
per [...]

Ashford and St Peter’s Hospitals NHS Trust Selects Newton for Theatre Utilisation Improvement Project

Targeting GBP1.6m of Annualised Savings Through Increasing and Optimising Theatre Utilisation at the Trust's two Hospital Sites

OXFORD, England, June 10, 2010 – Newton, Europe's leading operational and financial improvement
specialist, today announced that Ashford and St Peter's Hospitals NHS Trust,
a leading Trust that is based across two hospital sites in Surrey, has chosen
Newton to deliver [...]

Elsevier Acquires Collexis, a Leading Developer of Semantic Technology and Knowledge Discovery Software for Research and Development Institutions

Acquisition Accelerates Elsevier's Ability to Help Researchers and Decision-Makers, Establish, Execute and Evaluate Research Strategies and Deliver Higher ROI

AMSTERDAM, June 10, 2010 – Elsevier (www.elsevier.com), the leading global
publisher of scientific, technical, and medical information products and
services, announced today the acquisition of assets from Collexis Holdings,
Inc. (www.collexis.com), a leading developer of semantic technology
and knowledge discovery [...]

New Interim Results From European Patient Survey Add Weight to Expert Call for Greater Clinical Consensus on Breakthrough Cancer Pain

Experts concerned that inadequate treatment strategies make cancer patients suffer unnecessarily

GLASGOW, Scotland, June 10, 2010 – Further results from the European Survey of
Breakthrough Cancer Pain(1) were presented for the first time today at the 6th
Research Congress of the European Association for Palliative Care (EAPC) in
Glasgow.
The survey, which is the first [...]

Chiltern Launches Collaborative Technologies

LONDON, June 10, 2010 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO), announced the launch of Collaborative Technologies.

"Chiltern's Collaborative Technologies is a turnkey solution reflecting
integrated processes and technology which offers a single access point to
clinical study data and the central document repository for the entire study
team. Our Data [...]

Nivestim(TM), a New Biosimilar Filgrastim, is Approved in Europe for the Prevention of Febrile Neutropenia Associated With Chemotherapy

Nivestim(TM), Hospira's filgrastim, has received approval from the European Commission (EC) for the prevention of febrile neutropenia (FN) and reduction in duration of chemotherapy-induced neutropenia (CIN)

LEAMINGTON SPA, England, June 10, 2010 – Hospira announced today that the EC has approved Nivestim(TM)
(filgrastim) for the prevention of FN, the most serious haematological
toxicity that occurs as a [...]

Boston Scientific Announces European Launch and First Implants of Platinum Chromium TAXUS(R) Element(TM) Stent System

CE Mark Approval Includes Specific Indication for Treatment of Diabetic Patients

NATICK, Massachusetts, June 10, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced the
market launch and first implants of its TAXUS(R) Element(TM)
Paclitaxel-Eluting Coronary Stent System in the European Union and other CE
Mark countries. The TAXUS Element Stent System is the Company's
third-generation drug-eluting stent (DES) [...]

O2h Continues to Support Senexis to Support Patent Filing Senexis Limited

CAMBRIDGE, England, June 14, 2010 – Executives from Senexis Limited (Cambridge,UK) signed an
agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis
with chemistry services to support a patent filing on a novel chemical series
that have shown potential in pre-clinical models, as disease modifying
treatments for Alzheimer's Disease.

Dr. Mark Treherne, CEO [...]

Fifteen Projects Researching Major Diseases now Underway Through EU-Industry Joint Venture

BRUSSELS, June 14, 2010 – The Innovative Medicines Initiative (IMI) presents today its first 15
research projects that are now up and running. The research will help speed
up the discovery and development of new medicines for some of the most
serious illnesses.

The successful take-off of the projects marks a key milestone for [...]

EU Decision on Nutritional Labelling: Alternative on the Home Stretch

Survey of the TU Chemnitz Confirms: Consumers Clearly Prefer the sCALe Food Labelling Over the GDA Industry Version

COLOGNE, Germany, June 16, 2010 – While on 16 June the European Parliament will discuss
in its first reading about the future of nutritional labelling a current
survey by the University of Technology (TU) Chemnitz shows: Developed by
scientists and [...]

Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound

Anti-VEGF PRS-050 is First Anticalin Tested in Humans
FREISING-WEIHENSTEPHAN, Germany, June 15, 2010 – Pieris AG announced today the initiation of a Phase I clinical trial in
cancer patients for its lead program, PRS-050, an anti-VEGF Anticalin. The
trial is an open-label, dose-escalating evaluation of the compound's safety
and tolerability in patients with solid tumors. Conducted at three [...]

Diabetes Care Devices Market In Brazil, Russia, India, China (BRIC) Worth $570.56 Million In 2014

DALLAS, Texas, June 15, 2010 – According to the new market research report, "Diabetes care
devices market in Brazil, Russia, India, China (BRIC)" published by
MarketsandMarkets (www.marketsandmarkets.com), the diabetes care
devices market in BRIC was approximately $257.55 million in 2009 and is
expected to reach $570.56 million in 2014 at an estimated CAGR of 17.24%
from 2009 to 2014.

[...]

Kendle Advances Early Stage Drug Development with ElMindA’s Innovative Brain Network Activation Technology

Kendle and ElMindA partner in the introduction of a unique technology providing objective, sensitive, neural network profiling of brain activity

CINCINNATI, June 15, 2010 – Kendle (Nasdaq: KNDL), a leading, global full-service clinical research
organization, today announced it now offers Brain Network Activation (BNA)
imaging providing a non-invasive platform for mapping, monitoring and
understanding brain electro-physiological network activity [...]

Global Rainmakers Partners with Hacousto for Launch of Their Premium Security Division

NEW YORK, June 15, 2010 – Global Rainmakers, Inc. (GRI), an intellectual property holding company
and advanced R&D laboratory, recently announced a channel distribution
partnership with Hacousto Group, based in Holland, to market GRI's
groundbreaking tokenless-biometric security offering to the Benelux region.

Global Rainmakers has created a suite of biometric products that meets
the demands [...]

C3i Launches TechCRO Offering to Extend Services to the Global Clinical Trial Marketplace

WASHINGTON, June 15, 2010 – C3i, the global leader supporting electronic data capture software,
announced today that it is launching a new offering, C3i TechCRO,
significantly extending its existing capabilities to better serve clients
running clinical trial operations around the world.

This new service includes the ability to host clinical data management
systems for clients, [...]

World Cup Penalty: Nation Smokes More

LONDON, June 15, 2010 – Research findings released by Nicorette(R) show that almost half (46%) of
smokers and ex-smokers anticipate smoking more or lighting up again when
watching the World Cup.[1]

Worryingly, 1 in 6 people who have quit within the last year (15%)
believe they are likely to light up again if their [...]

CorMatrix(R) ECM(TM) Receives CE Mark for Cardiac Tissue Repair

Product Launches in Berlin at ISMICS Annual Meeting
ATLANTA, June 15, 2010 – CorMatrix(R) Cardiovascular, a medical device company dedicated to
developing and delivering unique extracellular matrix (ECM) biomaterial
devices that harness the body's innate ability to repair damaged
cardiovascular tissue, announced today it has received CE mark for its
CorMatrix ECM for Cardiac Tissue Repair. With this designation, [...]

Ugandan AIDS Patients and Care Providers to Fight Caps on Access to Lifesaving Treatment: Kampala Press Conference Wednesday, June 16th 11am

As Global Funders Retreat, Patients and Activists from the Consortium forAccess to AIDS Treatment (CAAT) and the National Forum for People Living with HIV/AIDS in Uganda (NAFOPHANU) will Unveil Plans for Protest March, Advocacy Efforts to Stop Thousands of Patients Already on Antiretroviral Therapy from Losing Access to Lifesaving Treatment

KAMPALA, Uganda, June 15, 2010 [...]

Personalized Treatments for Cancer Are Revolutionizing Patient Care

PORTLAND, Oregon, June 15, 2010 – Raju Kucherlapati, Professor of Genetics at Harvard University-where he
pioneered the use of genomic data in clinical decision making-will be
addressing the Controlled Release Society on the subject of recent
revolutionary advancements in personalized treatments for cancer patients.

"If you were diagnosed with non small cell lung cancer [...]

EMEA Approves Update to Velcade(R) (bortezomib) Label to Include Survival Benefit in Previously Untreated Patients with Multiple Myeloma

Additional Data Demonstrating Efficacy of bortezomib Presented at the 15th Congress of the European Hematology Association

BEERSE, Belgium, June 15, 2010 – Janssen-Cilag today welcomes the approval by the European Commission of
the update to the Summary of Product Characteristics (SmPC) for Velcade(R)
(bortezomib) for the treatment of patients with multiple myeloma. The update
includes data on overall [...]

EMA Approves Update to Velcade(R) (bortezomib) Label to Include Long Term (3 Year Follow up) Overall Survival Benefit in Previously Untreated Patients with Multiple Myeloma

Additional Data Demonstrating Efficacy of Velcade Presented at the 15th Congress of the European Hematology Association

BEERSE, Belgium, June 15, 2010 – Janssen-Cilag today welcomes the approval by the European Commission of
the update to the Summary of Product Characteristics (SmPC) for Velcade(R)
(bortezomib) for the treatment of patients with multiple myeloma. The update
includes extended follow-up data [...]

Frost & Sullivan: User-friendly and Superior Patient Monitoring Devices to Drive the Continuous Glucose Monitoring Market in Europe

LONDON, June 16, 2010 – The continuous glucose monitoring (CGM) market is in its development
stage. The primary factor leading to the growth of the (CGM) market in Europe
is the need for an easy-to-use and patient-friendly glucose-monitoring
device. The traditional method of monitoring glucose was difficult and
inconvenient for patients. The CGM method is not only hassle-free, [...]

Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets (Pharmaceuticals, Medical Devices and Health Insurance)

DALLAS, June 16, 2010 – The Healthcare practice at MarketsandMarkets is pleased to announce a new
report titled Obama's Healthcare Reform Bill and its Impact on the U.S.
Healthcare Markets (Pharmaceuticals, Medical devices and Health insurance).

Browse in-depth TOC on Obama's Healthcare Reform Market Report.
Early buyers will receive 10% customization of reports
www.marketsandmarkets.com/Market-Reports/Impact-Obama-Health-US-240.ht
ml

[...]

Emerging Markets (BRIC – Brazil, Russia, India and China): Patient Monitors 2010 – 2014

DALLAS, June 16, 2010 – The Healthcare practice at MarketsandMarkets is pleased to announce a new
report titled Emerging Markets (BRIC – Brazil, Russia, India and China):
Patient Monitors 2010 – 2014.

Browse in-depth TOC on BRIC Emerging Markets Report.
Early buyers will receive 10% customization of reports
www.marketsandmarkets.com/Market-Reports/Emerging-Markets-243.html
MARKET OVERVIEW

[...]

MarketsandMarkets Published World Dental Implants Market (2010 -2015) Market Research Report

DALLAS, June 16, 2010 – The Medical Devices practice at MarketsandMarkets is pleased to announce
a new report titled World Dental Implants Market (2010 -2015).

Browse in-depth TOC on World Dental Implants Market (2010 -2015).
Early buyers will receive 10% customization of reports
www.marketsandmarkets.com/Market-Reports/Dental-Implants-Market-241.ht
ml
(Due to the length of this URL, [...]

CSafe Signs Master Lease With Cathay Pacific Airways to Further Enhance Healthcare and Pharmaceutical Transport

DAYTON, Ohio, June 16, 2010 – CSafe, LLC, www.csafellc.com, manufacturer of the AcuTemp(R) RKN
active temperature controlled cargo container, and Cathay Pacific,
www.cathaypacific.com, one of the world's top ten international
providers of air cargo services, have signed a master lease agreement for
CSafe's active temperature controlled containers.

The agreement enhances the product offerings provided by [...]

Independent Study Reveals dabl System Leads the way in Accurate Cardiovascular Diagnosis

DUBLIN, June 17, 2010 – An independent study has revealed that Irish Company, dabl's
computerised system for diagnosing 24 hour blood pressure is more accurate
and consistent than a leading group of international hypertension experts.

Conducted by the Western General Hospital in Edinburgh, the study
analysed the interpretation of numerous blood pressure readings taken [...]

Diagnostic Imaging Markets in Brazil, Russia, India, China (BRIC) 2010 – 2015: MarketsandMarkets

DALLAS, June 17, 2010 – The Medical Device practice at MarketsandMarkets is pleased to announce a
new report titled Diagnostic Imaging Markets in Brazil, Russia, India, China
(BRIC) 2010 – 2015.

Browse in-depth TOC on Diagnostic Imaging Markets in Brazil, Russia,
India, China (BRIC) 2010 – 2015 Market Report. Early buyers will receive 10%
customization [...]

Effective Social Media Marketing Strategies for Pharmaceutical Market (2010 – 2015): MarketsandMarkets

DALLAS, June 17, 2010 – The Pharmaceutical practice at MarketsandMarkets is pleased to announce a
new report titled Effective Social Media Marketing Strategies for
Pharmaceutical Market (2010 – 2015).

Browse in-depth TOC on Effective Social Media Marketing Strategies for
Pharmaceutical Market (2010 – 2015)
Early buyers will receive 10% customization of [...]

Shire plc Appoints Two New Board Directors

Non-Executives to Join Shire's Science & Technology and Remuneration Committees

DUBLIN, June 17, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that Dr David Ginsburg and Ms Anne Minto
OBE, have been appointed to the Shire Board of Directors with immediate
effect.
Dr Ginsburg, MD is currently Professor of [...]

Ethnicity Key Factor in Determining Cardiovascular Risk Profile

New Data From Most Comprehensive Comparison of Cardiovascular Risk Profiles Across Four Largest Racial-Ethnic Groups

BEIJING, June 17, 2010 – Racial-ethnic groups living in a similar environment and with access to
universal healthcare differed strikingly in their cardiovascular risk
profiles according to new data presented today at the World Congress of
Cardiology (WCC) Scientific Sessions in Beijing, China.
[...]

Medtronic Announces European Launch of Protecta(TM) Portfolio With SmartShock(TM) Technology Shown to Significantly Reduce Inappropriate Shocks

New Data Released at Cardiostim 2010 Shows Benefits of Advanced Shock Reduction Technologies

NICE, France, June 17, 2010 – Medtronic, Inc. (NYSE:MDT) today announced European launch of the
Protecta(TM) portfolio of implantable cardioverter-defibrillators (ICDs) and
cardiac resynchronization therapy-defibrillators (CRT-Ds). The implantable
defibrillators feature Medtronic-exclusive SmartShock(TM) Technology,
comprised of six advanced shock-reduction algorithms that can significantly
reduce inappropriate shocks. Findings from [...]

Frost & Sullivan to Host Complimentary Briefing on the European Point of Care Testing Market: Will the Benefits Overrule the Challenges?

LONDON, June 17, 2010 – Advances in analytical technology and healthcare services have led to a
significant progress in the development of point of care (POC) testing,
resulting in rising demand for test devices at the site of the patient. Some
POCT devices like urine and glucose dipsticks and meters have been used in
the hospital environment, general [...]

Young Single Men Are Oblivious to High Blood Pressure

New Data From The World Congress Of Cardiology
BEIJING, June 19, 2010 – Younger, unmarried men around the world are least likely to be aware of
hypertension (high blood pressure) and less likely to be receiving treatment.
Whereas older women, are most aware of hypertension according to data
presented today at the World Congress of Cardiology (WCC) Scientific [...]

Erectile Dysfunction – Marker for Heart Attack

New Data From the World Congress of Cardiology
BEIJING, June 19, 2010 – Seven out of 10 men admitted to hospital for a heart attack (acute ST
segment elevation myocardial infarction (STEMI)) had erectile dysfunction
(ED) in the six months prior to their admission according to new data
presented today at the World Congress of Cardiology (WCC) Scientific [...]

Boris Johnson Meets London Companies in South Africa

CAPE TOWN, South Africa, June 18, 2010 – The Mayor of London, Boris Johnson, today (18.610) met with
London companies operating in South Africa as part of his five-day
fact-finding mission into hosting major international sporting events.

The companies, which met the Mayor at Input Media's
spectacular World Cup studio on the V&A Waterfront [...]

Top 10 Drug Delivery Technologies (2010 – 2015): MarketsandMarkets

DALLAS, Texas, June 21, 2010 – The Pharmaceutical practice at MarketsandMarkets is pleased to announce a
new report titled Top 10 Drug Delivery Technologies (2010 – 2015).

Browse in-depth TOC on Top 10 Drug Delivery Technologies (2010 – 2015)
Early buyers will receive 10% customization of reports
www.marketsandmarkets.com/Market-Reports/top-10-drug-delivery-technolo
gies-112.html
[...]

Cardiovascular Devices Market Outlook June Update by ReportsandReports

DALLAS, June 21, 2010 – ReportsandReports announces it Will Carry Cardiovascular Devices Market
Outlook 2016 June reports in its store.

Netherlands Cardiovascular Devices Market Outlook to 2016 (
www.reportsandreports.com/market-reports/netherlands-cardiovascular-de
vices-market-outlook-to-2016/)

(Due to the length of these URLs, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL [...]

Generic Drug Makers Ranked in New ‘Access to Medicine Index’

Indian Firms Less Open About Efforts for Low-income Countries Than Originator Companies

AMSTERDAM, June 20, 2010 – Generic drug makers are less transparent about programs to make medicines
available to people in developing countries than originator companies in
Europe and the United States. Overall, European drug companies are leading in
this area, according to the second Access to [...]

Indian Drug Makers Ranked in New ‘Access to Medicine Index’

Generic Firms Less Open About Efforts for Low-income Countries Than Originator Companies

AMSTERDAM, June 20, 2010 – Generic drug makers in general are less transparent about programs to
make medicines available to people in developing countries than originator
companies in Europe and the United States. Overall, European drug companies
are leading in this area, according to the second [...]

European Drug Companies Lead ‘Access to Medicine Index’

Independent Ranking Shows More Transparency, More Programs for Low-income Countries

AMSTERDAM, June 20, 2010 – European pharmaceutical companies outcompete their U.S. counterparts in
making medicines available to people in developing countries, but their lead
is shrinking, according to the second Access to Medicine Index, released
today.
Compared to 2008, when the first Index was published, [...]

Japanese Pharma Companies Ranked in ‘Access to Medicine Index’

Global Ranking Shows More Transparency, More Programs for Low-income Countries

AMSTERDAM, June 20, 2010 – For the first time, Japanese pharmaceutical companies were ranked with
their U.S. and European counterparts on a global Index comparing companies'
efforts to make medicines available to the people in developing countries.
Overall, European drug companies are leading in this area, according to [...]

Zydus’ Novel Orally Administered GLP-1 Agonist – ‘ZYOG1′ to treat Diabetes and Obesity Enters Phase I Clinical Trial

AHMEDABAD, India, June 21, 2010 – Zydus Cadila, a global healthcare provider and one of India's
leading healthcare companies has received Phase I clinical trial permission
from the DCGI for ZYOG1 – a novel GLP-1 agonist. Designed and developed at
the Zydus Research Centre using a unique platform technology, ZYOG1 is a
novel, oral, anti-diabetic molecule.

[...]

GW Announces UK Launch of World’s First Prescription Cannabis Medicine

Sativex(R) Marketed to Treat Spasticity Associated with Multiple Sclerosis
PORTON DOWN, England, June 21, 2010 – GW Pharmaceuticals plc (GWP:AIM) today announces the UK launch
of Sativex(R), its Oromucosal Spray for the treatment of spasticity due to
Multiple Sclerosis (MS). Sativex(R) is the world's first prescription
cannabis medicine and the UK is the first country in the world [...]

Stallergenes: Staloral(R) Mites 300 Clinical Study in China: Efficacy is Demonstrated

ANTONY, France, June 21, 2010 – Stallergenes S.A. announces the results of a phase III
clinical trial (VO55.06) conducted in China aimed at assessing the efficacy
and safety of sublingual immunotherapy (Staloral(R) mites 300) in adult
patients suffering from asthma triggered by house dust mites.

Study VO55.06 is a phase III randomized, double-blind,
placebo-controlled study [...]

Vitala(TM) Continence Control Device Receives CE Mark Extending Daily Wear Time Up to 12 Hours

Innovative Pouchless Ostomy Management System for People with a Colostomy
SKILLMAN, New Jersey, June 21, 2010 – ConvaTec, a world-leading developer and marketer of innovative medical
technologies for community and hospital care, announced today that the
Vitala(TM) Continence Control Device (CCD), the company's novel, non-invasive
pouchless ostomy device that provides temporary continence for people with an
end colostomy, has [...]

Government Initiatives Support the South African Dental Products Market, Finds Frost & Sullivan

CAPE TOWN, South Africa, June 21, 2010 – The South African Government's policies regarding the new National Health
Insurance (NHI) scheme should significantly enhance the South African dental
products market. By creating greater access to dental treatments, this
initiative will not only improve basic dental services, but also increase the
number of elective surgeries, brightening the prospects of [...]

Top 10 Drug Delivery Technologies (2010 – 2015): MarketsandMarkets

DALLAS, Texas, June 21, 2010 – The Pharmaceutical practice at MarketsandMarkets is pleased to announce a
new report titled Top 10 Drug Delivery Technologies (2010 – 2015).

Browse in-depth TOC on Top 10 Drug Delivery Technologies (2010 – 2015)
Early buyers will receive 10% customization of reports
www.marketsandmarkets.com/Market-Reports/top-10-drug-delivery-technolo
gies-112.html
[...]

Cardiovascular Devices Market Outlook June Update by ReportsandReports

DALLAS, June 21, 2010 – ReportsandReports announces it Will Carry Cardiovascular Devices Market
Outlook 2016 June reports in its store.

Netherlands Cardiovascular Devices Market Outlook to 2016 (
www.reportsandreports.com/market-reports/netherlands-cardiovascular-de
vices-market-outlook-to-2016/)

(Due to the length of these URLs, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL [...]

Kelly Brook Voted Best Celebrity Body

POOLE, England, June 21, 2010 – Kelly Brook has been voted as number one celebrity body in a new survey
commissioned by Fitness First.

The world's largest privately owned health club group surveyed over 2,000
people to rate celebrity bodies and their own personal fitness goals. Actress
and model Kelly Brook was voted the [...]

Caduet Reduces 10-Year Calculated Risk of Coronary Heart Disease, Fatal Cardiovascular Disease

OSLO, Norway, June 21, 2010 – Caduet(R) (amlodipine besylate/atorvastatin calcium) was associated with
a significantly reduced calculated 10-year risk of coronary heart disease
(CHD) based on a Framingham risk assessment model. In addition, Caduet was
shown to reduce calculated fatal cardiovascular disease (CVD) risk, as a
secondary trial endpoint based on the SCORE risk assessment model. The
Framingham and [...]

New 2009 Impact Factors Soar for Newest Cell Press Journals

Impressive Increases for Cell Stem Cell and Cell Host and Microbe Rankings; Cell Remains Top Journal in its Field

CAMBRIDGE, Massachusetts, June 21, 2010 – In the year since their 2008 preliminary ranking, Cell Press journals
Cell Stem Cell and Cell Host and Microbe saw their Impact Factors surge,
according to new data released in the 2009 [...]

World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets

DALLAS, Texas, June 21, 2010 – The Pharmaceuticals practice at MarketsandMarkets is pleased to announce
a new report titled World Low Calorie/Diet Beverages Market (2010 -2015).

Browse in-depth TOC on World Low Calorie/Diet Beverages Market (2010
-2015)Market Report. Early buyers will receive 10% customization of reports
www.marketsandmarkets.com/Market-Reports/low-calorie-248.html
Low-calorie beverages form the [...]

World Diet Food and Confectionery Market (2010 -2015): MarketsandMarkets

DALLAS, June 21, 2010 – The Pharmaceuticals practice at MarketsandMarkets is pleased to announce
a new report titled World Diet Food And Confectionery Market (2010 – 2015).

Browse in-depth TOC on World Diet Food and Confectionery Market (2010
-2015) Market Report. Early buyers will receive 10% customization of reports
www.marketsandmarkets.com/Market-Reports/diet-food-247.html
The [...]

Patients with Hypertension at Risk Due to Physician Inertia

New Supporting Hypertension Awareness and Research Europe-wide (SHARE) Survey Reports Findings at the 20th Annual Society of the European Society of Hypertension (ESH)

OSLO, June 21, 2010 – Data announced for the first time at ESH suggest that patients
with hypertension are at increased cardiovascular risk due to clinician
inertia, because physicians are failing to treat targets [...]

Kent-Based Former Vet’s Application for Restoration to RCVS Register Refused

LONDON, June 21, 2010 – The Disciplinary Committee of the Royal College of Veterinary Surgeons
has refused an application for restoration to the RCVS Register from a
Kent-based former veterinary surgeon struck off in 1994 for disregarding
basic hygiene at his professional premises and failing to properly maintain a
Controlled Drugs Register or patient records.

[...]

US$25 Million Commitment to the West Wireless Health Institute Brings Total Funding from Gary and Mary West Foundation to Nearly US$100 Million Since Institute’s Inception in March 2009

Additional Funding will Support Continued Recruitment of World Class Engineering Talent

SAN DIEGO, June 21, 2010 – The Gary and Mary West Foundation today announced a US$25 million
commitment to enable the West Wireless Health Institute (WWHI) to amplify its
aggressive recruitment of world class engineering talent and accelerate its
mission on a national and global scale. The [...]

CareFusion, Cisco and Medtronic to Collaborate With West Wireless Health Institute on Technology and Educational Initiatives

Companies demonstrate continued commitment to accelerate emerging wireless health industry

SAN DIEGO, June 21, 2010 – The West Wireless Health Institute (WWHI) today announced CareFusion,
Cisco and Medtronic have joined its roster of Technology and Education (T&E)
partners. Each company plans to work closely with the Institute's clinical
and engineering teams on a variety of research, technology and [...]

Treating the Root Cause: Misdiagnosis Leads to Life Saving Treatment

LONDON, June 21, 2010 – Conflicts and wars not only take their toll on human lives, but also on
the local environment. Whilst much publicity is focused on International
efforts to help rebuild Afghanistan's economy and social structures, less
well known is the – often voluntary – work going on to rebuild the
environment, part of which involves [...]

Generic Drug Makers Ranked in New ‘Access to Medicine Index’

Indian Firms Less Open About Efforts for Low-income Countries Than Originator Companies

AMSTERDAM, June 20, 2010 – Generic drug makers are less transparent about programs to make medicines
available to people in developing countries than originator companies in
Europe and the United States. Overall, European drug companies are leading in
this area, according to the second Access to [...]

Indian Drug Makers Ranked in New ‘Access to Medicine Index’

Generic Firms Less Open About Efforts for Low-income Countries Than Originator Companies

AMSTERDAM, June 20, 2010 – Generic drug makers in general are less transparent about programs to
make medicines available to people in developing countries than originator
companies in Europe and the United States. Overall, European drug companies
are leading in this area, according to the second [...]

European Drug Companies Lead ‘Access to Medicine Index’

Independent Ranking Shows More Transparency, More Programs for Low-income Countries

AMSTERDAM, June 20, 2010 – European pharmaceutical companies outcompete their U.S. counterparts in
making medicines available to people in developing countries, but their lead
is shrinking, according to the second Access to Medicine Index, released
today.
Compared to 2008, when the first Index was published, [...]

Japanese Pharma Companies Ranked in ‘Access to Medicine Index’

Global Ranking Shows More Transparency, More Programs for Low-income Countries

AMSTERDAM, June 20, 2010 – For the first time, Japanese pharmaceutical companies were ranked with
their U.S. and European counterparts on a global Index comparing companies'
efforts to make medicines available to the people in developing countries.
Overall, European drug companies are leading in this area, according to [...]

ExAblate(R) Receives European CE Mark for Treatment of Adenomyosis

Non-Invasive Procedure Now Available Where Options Were Limited; InSightec Innovation Continues to Expand Treatment Choice in Women's Health

TIRAT CARMEL, Israel, June 23, 2010 – InSightec Ltd. announced today that its ExAblate(R) system has received
an expanded CE Mark certification for "ablation of soft tissue for treatment
of benign tumors, including uterine fibroids and adenomyosis" using Magnetic
Resonance [...]

1 Million Reproductive Treatments Documented

Ninety Per Cent of all IVF Centers Record Reproductive Treatments With RecDate Advance

REGENSBURG, Germany, June 23, 2010 – Dr. Klaus Buhler, President of the German IVF Register, has reported the
one-millionth treatment cycle in reproductive medicine recorded by the IVF
Register in Germany this year. Presently, ninety per cent of all centers for
in-vitro fertilization (IVF) in [...]

Frost & Sullivan: Rising Obesity Rates Drive the Global Weight Management Ingredients Market

LONDON, June 23, 2010 – Obesity rates, which have been steadily rising in Europe and the United
States, are now increasing in Asian nations as well. While healthy eating and
lifestyle management are the key solutions to weight management, they remain
challenging for many consumers. As a result, the weight management
ingredients market offers significant prospects worldwide.

[...]

Santaris Pharma A/S and miRagen Therapeutics, Inc. Form Strategic Alliance to Develop microRNA-Targeted Medicines for the Treatment of Cardiovascular Disease

miRagen licenses rights to utilize Santaris Pharma A/S proprietary Locked Nucleic Acid (LNA) Drug Platform to identify and select drug candidates against miRagen's proprietary microRNA targets for the treatment of cardiovascular disease

HOERSHOLM, Denmark, SAN DIEGO and BOULDER, Colorado, June 23, 2010 – Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused
on the discovery and development [...]

Pharmaceuticals and Healthcare Report Q3 2010 Market Research and Analysis June Update by ReportsandReports

DALLAS, June 23, 2010 – ReportsandReports announces it will carry Pharmaceuticals and Healthcare
Market Research Report June update in its store.

Bangladesh Pharmaceuticals and Healthcare Report Q3 2010
(www.reportsandreports.com/market-reports/bangladesh-
pharmaceuticals-and-healthcare-report-q3-2010/)
Out of the 16 key markets surveyed in BMI's Pharmaceuticals & Healthcare
Business Environment Ratings, Bangladesh moves up two places to occupy [...]

Rentabiliweb Acquires the Yves Rocher Group’s News and Shopping Portal

The Rentabiliweb Group Embarks Upon its Development Strategy via External Growth With the Acquisition of Very High Valued-Added "Health and Well-Being" Content With a Select Female Audience Fond of Online Shopping

BRUSSELS, June 22, 2010 – Rentabiliweb is announcing that it has acquired all of the
editorial, brand and database content of "Clic Bien Etre", the [...]

ConvaTec Introduces Flexi-Seal(TM) SIGNAL(TM) FMS

A new solution from the Flexi-Seal(TM) FMS family of fecal management systems that helps clinicians seal their patients' protection

SKILLMAN, New Jersey, June 23, 2010 – ConvaTec, a world-leading developer and marketer of innovative medical
technologies for community and hospital care, announced today the launch of
Flexi-Seal(TM) SIGNAL(TM) Fecal Management System (FMS). Now available in
several key European [...]

Dr. Nono Simelela, CEO of the South Africa National Aids Council, is now an Official Ambassador of the Global HIV Awareness and Charity Campaign GOALS for SOUTH AFRICA

COLOGNE, Germany, June 22, 2010 – The global HIV awareness and charity campaign GOALS for SOUTH
AFRICA announces its first official ambassador from South Africa, Dr. Nono
Simelela, CEO of the South Africa National Aids Council (SANAC). According to
the latest UNAIDS statistics, more than five million people in the host
country of this year's FIFA World Cup [...]

Diamyd Medical Signs Agreement for Diabetes Therapy

STOCKHOLM, Sweden, June 22, 2010 – Diamyd Medical AB has signed an agreement with
Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson
company, to develop and commercialize the Diamyd(R) diabetes therapy.

(Logo: www.newscom.com/cgi-bin/prnh/20080314/297194 )
The agreement relates to the development and world-wide
commercialization of the GAD65 antigen-based therapy (Diamyd(R)) for [...]

Elsevier Middle East Announces Call for Papers

Elsevier Planning to Continue Raising the Bar Where High Standards for Medical Journals are Concerned

AMMAN, Jordan, June 22, 2010 – Elsevier, a world-leading healthcare and scientific publisher, announced
today that it is open to submission for medical papers on cutting edge
medical topics.
Elsevier Middle East is quickly expanding to fill a void [...]

European Remote Patient Monitoring Market Expected to Witness High Growth Rates – Frost & Sullivan Hosts Complimentary Analyst Briefing

LONDON, June 22, 2010 – Across Europe, governments have realized the need to introduce remote
monitoring into the mainstream of healthcare services. Currently, the market
experiences heavy investment regarding the development of various patient
monitoring systems using information and communication technology and
enabling the remote monitoring of a patient. The European Healthcare sector
seems finally ready to embrace the [...]

Frost & Sullivan Research Rates LifeSize Communications Highest Among HD Video Communications Providers Serving the Healthcare Market

LifeSize Delivers Industry-Leading Price Performance, Ease-of-Use and Service, with Innovative Features Best-Matched to Telemedicine Requirements

LONDON, June 22, 2010 – Based on its recent research in the global healthcare market, Frost &
Sullivan has presented LifeSize with the 2010 Global Visual Collaboration
Price Performance Value Leadership Award. Among competitors, Frost & Sullivan
named LifeSize HD video communications solutions [...]

Resverlogix Scientific Data Presented at EAS Congress

New data from Phase 1b/2a Trial Included
HAMBURG and CALGARY, Canada, June 22, 2010 – Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced
today that key scientific data was communicated in an oral presentation
highlighting the novel features of the Company's lead drug RVX-208 at the
European Atherosclerosis Society Congress (EAS) conference being held in
Hamburg, Germany. The presentation [...]

Kelly Brook Voted Best Celebrity Body

POOLE, England, June 21, 2010 – Kelly Brook has been voted as number one celebrity body in a new survey
commissioned by Fitness First.

The world's largest privately owned health club group surveyed over 2,000
people to rate celebrity bodies and their own personal fitness goals. Actress
and model Kelly Brook was voted the [...]

Caduet Reduces 10-Year Calculated Risk of Coronary Heart Disease, Fatal Cardiovascular Disease

OSLO, Norway, June 21, 2010 – Caduet(R) (amlodipine besylate/atorvastatin calcium) was associated with
a significantly reduced calculated 10-year risk of coronary heart disease
(CHD) based on a Framingham risk assessment model. In addition, Caduet was
shown to reduce calculated fatal cardiovascular disease (CVD) risk, as a
secondary trial endpoint based on the SCORE risk assessment model. The
Framingham and [...]

New 2009 Impact Factors Soar for Newest Cell Press Journals

Impressive Increases for Cell Stem Cell and Cell Host and Microbe Rankings; Cell Remains Top Journal in its Field

CAMBRIDGE, Massachusetts, June 21, 2010 – In the year since their 2008 preliminary ranking, Cell Press journals
Cell Stem Cell and Cell Host and Microbe saw their Impact Factors surge,
according to new data released in the 2009 [...]

World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets

DALLAS, Texas, June 21, 2010 – The Pharmaceuticals practice at MarketsandMarkets is pleased to announce
a new report titled World Low Calorie/Diet Beverages Market (2010 -2015).

Browse in-depth TOC on World Low Calorie/Diet Beverages Market (2010
-2015)Market Report. Early buyers will receive 10% customization of reports
www.marketsandmarkets.com/Market-Reports/low-calorie-248.html
Low-calorie beverages form the [...]

World Diet Food and Confectionery Market (2010 -2015): MarketsandMarkets

DALLAS, June 21, 2010 – The Pharmaceuticals practice at MarketsandMarkets is pleased to announce
a new report titled World Diet Food And Confectionery Market (2010 – 2015).

Browse in-depth TOC on World Diet Food and Confectionery Market (2010
-2015) Market Report. Early buyers will receive 10% customization of reports
www.marketsandmarkets.com/Market-Reports/diet-food-247.html
The [...]

Patients with Hypertension at Risk Due to Physician Inertia

New Supporting Hypertension Awareness and Research Europe-wide (SHARE) Survey Reports Findings at the 20th Annual Society of the European Society of Hypertension (ESH)

OSLO, June 21, 2010 – Data announced for the first time at ESH suggest that patients
with hypertension are at increased cardiovascular risk due to clinician
inertia, because physicians are failing to treat targets [...]

Kent-Based Former Vet’s Application for Restoration to RCVS Register Refused

LONDON, June 21, 2010 – The Disciplinary Committee of the Royal College of Veterinary Surgeons
has refused an application for restoration to the RCVS Register from a
Kent-based former veterinary surgeon struck off in 1994 for disregarding
basic hygiene at his professional premises and failing to properly maintain a
Controlled Drugs Register or patient records.

[...]

Frost & Sullivan: Escalating Costs of Drug Development Drive the Pharmaceutical Companies to Tap Opportunities in Emerging Markets

LONDON, June 24, 2010 – The increased cost of drug development has impelled pharmaceutical
companies to seek better opportunities in emerging markets to successfully
expand and sell their products. Most pharmaceutical companies consider
emerging markets lucrative due to their economical infrastructure and
manpower costs and a significant untapped market potential with a large
population.

(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
[...]

Occlutech Prevails in U.K. Patent Appeal by AGA Medical

JENA, Germany, June 24, 2010 – In 2009 the Patents Court of the High Court, Chancery Division, decided
that Occlutech's range of Figulla ASD and PFO occluders do not infringe the
U.K. part of European Patent 0 808 138. AGA Medical decided to appeal against
this decision. The U.K. Court of Appeal (civil division) in London announced
its [...]

IDEV Technologies Enters Into an Exclusive Distribution Agreement With TriReme Medical

Company Expands Product Portfolio
WEBSTER, Texas, June 24, 2010 – IDEV Technologies, Incorporated (IDEV), an emerging leader in the
development and marketing of minimally invasive medical technologies, today
announced that it has entered into an exclusive distribution agreement
covering the U.S. and Germany for TriReme Medical, Inc.'s (TriReme)
GliderXtreme(TM) PTA balloon catheter, an advanced product with specific
features for the [...]

Diabetes Care Devices Market in Brazil, Russia, India, and China (BRIC) (2010 – 2014) Now Available at ReportsandReports

DALLAS, Texas, June 24, 2010 – ReportsandReports announces it will carry the Diabetes Care Devices
Market in Brazil, Russia, India, and China (BRIC) (2010 – 2014) Market
Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/diabetes-care-devices-mar
ket-in-brazil-russia-india-and-china-/
(Due to the length of this URL, it may [...]

MDS Nordion, Guerbet, and Cyceron Announce Partnership to Develop New Diagnostic Agents

Collaboration Will Assess New and Innovative Imaging Agents for Cancer Detection

OTTAWA, June 24, 2010 – MDS Nordion, a leading provider of products and services to the
global health science market, Guerbet, a pharmaceutical group specialized
in medical imaging, and Cyceron, a biomedical imaging centre in
France, announced today they have entered into an agreement to develop new
Positron [...]

‘It Takes All Kinds’ – an Innovative MRI System Which is Open for all Patients – OASIS(TM)

Hitachi Medical Systems UK Sells its First 1.2 Tesla Open Architecture Vertical High-Field MRI System to Mayday Hospital, Croydon

LONDON, June 24, 2010 – Mayday Hospital – Hitachi Medical Systems UK has been awarded
the contract for OASIS(TM) 1.2 Tesla high-field open MRI by InHealth MRI
Centre at Mayday Hospital, Croydon – the high performance system with [...]

China Pharma Events Attract Record Attendance

AMSTERDAM, June 24, 2010 – Leading events organiser UBM International Media and sister company UBM
Sinexpo today announced that a record attendance of 26,547 at its 2010
Chinese Pharma events cluster — CPhI China for intermediates and APIs; P-MEC
for equipment and machinery; plus trails for ICSE Contract Services; and
BioPh for the biopharma sector — representing an [...]

Elsevier Announces New Medical Hypotheses Editor-in-Chief

Dr. Mehar Manku Assumes Leadership of Unique Journal, Vowing to Embrace the Journal's Original Ethos While Implementing a Different Approach to the Peer Review Process

OXFORD, England, June 24, 2010 – Elsevier (www.elsevier.com) announced today that Dr.
Mehar Manku has accepted the position of Editor-in-Chief of the journal
Medical Hypotheses (www.elsevier.com/wps/find/journaldescription.cws
_home/623059/description#description). In this role Dr. Manku will [...]

New High-Resolution Computer Tomography Data Demonstrates EVISTA(R)’s Effect on Bone Quality in Osteoporotic Patients

3D Images Provide New Approach to Monitoring Bone Changes
MUNICH, June 28, 2010 – Interim data from a prospective Investigator Initiated Trial
(IIT) presented today at the ECTS, the 37th European Symposium on Calcified
Tissues, in Glasgow, demonstrates that EVISTA(R) (raloxifene 60mg;
once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the
treatment and prevention of osteoporosis in [...]

Kowa Company, Ltd. Grants Abbott Exclusive Rights to Market Pitavastatin Calcium, a Lipid-lowering Drug, in Australia and New Zealand

WOKINGHAM, England, June 28, 2010 – Following an enthusiastic expansion programme into new markets, Kowa
Company, Ltd. (President: Yoshihiro Miwa), headquartered in Nagoya, Japan,
has granted Abbott, headquartered in Illinois, USA the exclusive license to
distribute and market pitavastatin calcium (brand name Livalo), a
lipid-lowering drug, in Australia and New Zealand. This agreement means that
pitavastatin will now be [...]

Enzymes Gain Importance as Process Aids in Food Applications, Finds Frost & Sullivan

LONDON, June 28, 2010 – During the economic slowdown in 2009, food enzymes were successfully
positioned as cost savers and process efficiency improvers in many
application segments. This strategy, along with increased R&D efforts, is
expected to continue to attract new applications such as interesterification
for the reduction of trans fats and as 'meat glue' (transglutaminases). While
the increased [...]

Chasing Happiness: Why Feeling Good Remains Elusive

SAN FRANCISCO, June 28, 2010 – Want happiness? While studies indicate that lots of friends, a high
paying job, or even passing years may create a higher likelihood of feeling
"happy," a reliable recipe for lasting happiness remains elusive, says The
Gnostic Movement. Lasting happiness will be the focus of a global Gnostic
event on July 10 in [...]

Gastrointestinal Disorders Therapeutics to 2016 – High Unmet Needs Triggering Strong Growth in Crohn’s Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports

DALLAS, June 28, 2010 – ReportsandReports announces it will carry the Gastrointestinal Disorders
Therapeutics to 2016 – High Unmet Needs Triggering Strong Growth in Crohn's
Disease and Irritable Bowel Syndrome Markets Market Research Report in its
store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/gastrointestinal-disorders-th
erapeutics-to-2016-high-unmet-need/
GBI Research's report, "Gastrointestinal disorders therapeutics, analysis
and forecasts to [...]

Indian Multinational Company Confirms USD 6 Million Order to Set up Industrial Waste Water Treatment Plants in Africa

CHENNAI, India, June 28, 2010 – Shivsu Canadian Clear International Ltd, a leading water technology
solution provider, has completed an order worth USD 6 million from the
private organizations and Government of Africa to set up industrial waste
water treatment plants in Kenya, Tanzania and Ethiopia. The company will be
involved in design, manufacture, supply and installation of [...]

Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients With Type 2 Diabetes at the American Diabetes Association Meeting

TOKYO, June 28, 2010 – Astellas Pharma Inc. (Headquarters: Tokyo, President & CEO: Masafumi
Nogimori, "Astellas") announced that the company presented results from a
Japanese Phase 2 study conducted with ASP1941, a selective SGLT2 inhibitor,
at the 70th Scientific Sessions of the American Diabetes Association (ADA) on
June 26, 2010 (EST). ASP1941 is designed to block the re-absorption [...]

The National Institute for Health & Clinical Excellence (NICE) Approves the Use of Radiofrequency Ablation for Treatment of Barrett’s Esophagus

Interventional Procedures (IPAC) Guidelines from NICE in the UK include Radiofrequency Ablation (RFA) for eradication of high grade dysplasia in patients with Barrett's Esophagus.

SUNNYVALE, California, June 28, 2010 – BARRX Medical Inc., a world leader in products to treat pre-cancerous
tissue in the esophagus, reported today that the National Institute for
Health and Clinical Excellence (NICE) [...]

Power Market in Western Europe to 2020 – Increasing Focus on Renewable Power to Change the Energy Mix Now Available at ReportsandReports

DALLAS, June 28, 2010 – ReportsandReports announces it will carry the Power Market in Western
Europe to 2020 – Increasing Focus on Renewable Power to Change the Energy Mix
Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/power-market-in-western-europ
e-to-2020-increasing-focus-on-rene/
GBI Research's report, "Power Market in Western Europe to 2020:
Increasing [...]

Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline

Second Deal in Six Months Expands CNS Portfolio to Four Programs
MAPLE GROVE, Minnesota, June 28, 2010 – Upsher-Smith Laboratories, Inc. today announced an agreement with Ikano
Therapeutics, Inc. to obtain exclusive global rights to ITI-111, Ikano's
nasal midazolam. Under terms of the agreement, Upsher-Smith will assume all
further development, testing and clinical study of nasal midazolam as [...]

Findings From Global Survey Help Understand Fertility Trends And Barriers to Seeking Medical Help Against Infertility

Over 10,000 Responded to the Largest International Study Aimed at Understanding the Decision-making Process of Couples Trying to Conceive

ROME, June 28, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today
announced the outcomes of the Global survey "Starting Families" at the 26th
edition of the annual meeting of the European Society of Human [...]

Frankfurt To Host World’s Largest Pharmaceutical Services Events In 2011

AMSTERDAM, June 28, 2010 – Leading events organiser UBM International Media today announced that its
flagship CPhI Worldwide tradeshow will return to Frankfurt, Germany for 2011.
Along with co-hosted events – P-MEC Europe for equipment, machinery and
technology; ICSE for contract services and packaging; and BioPh Europe for
the biopharma sector – the world's leading pharma services industry [...]

Mr. Jean-Pierre Garnier Concludes his Mission at the Pierre Fabre Company

CASTRES, France, June 28, 2010 – Mr Jean-Pierre Garnier will step down on September 1st 2010,
two years after having been appointed CEO of the Pierre Fabre Group.

"The Company is in excellent health, and is poised to
experience a bright future ; I am glad to have contributed to its success and
I [...]

Twelve Women Scientists Announced as Winners of Elsevier Foundation TWOWS Awards

Outstanding Young Women Biologists, Chemists, Physicists and Mathematicians Recognized Across the Developing World

BEIJING, June 27, 2010 – The Elsevier Foundation, TWAS and TWOWS announced today that they are
recognizing twelve talented women scientists from Africa, the Middle East,
Asia, Latin America and the Caribbean for their research excellence. The
announcement was made at the Third World Organization [...]

Results From Study of Vascular Calcification in Dialysis Patients Presented in Late-Breaking Clinical Trial Session at ERA-EDTA 2010 Congress

MUNICH, June 26, 2010 – Results from the ADVANCE study presented in a late breaking clinical
trial session at the ERA-EDTA 2010 Congress provide new insights into the
management of secondary hyperparathyroidism (SHPT) in chronic kidney disease
(CKD) patients. ADVANCE (A randomiseD VAscular calcificatioN study to
evaluate the effects of CinacalcEt) is a randomised, controlled open label
study to [...]

ONGLYZA(TM) (saxagliptin) With Metformin As Initial Combination Therapy Provided 76-Week Long-Term Glycemic Control In Treatment-Naive Adults With Type 2 Diabetes

Not for US Media
ORLANDO, Florida, June 26, 2010 – Bristol-Myers Squibb Company (NYSE: BMY)
and AstraZeneca (NYSE: AZN) today announced results up to 76-weeks from a
Phase 3 study of ONGLYZA(TM) (saxagliptin) as initial combination therapy
with metformin, which produced long-term glycemic improvement [as measured
by glycosylated hemoglobin level (HbA1c)] in treatment-naive adults with
type 2 diabetes mellitus inadequately [...]

52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added To Metformin Was Non-Inferior To Titrated Glipizide When Added To Metformin In Reducing Glycosylated Hemoglobin (HbA1c) In Adults With Type 2 Diabetes Mellitus

Not for US Media
ORLANDO, Florida, June 26, 2010 – Bristol-Myers Squibb Company (NYSE: BMY)
and AstraZeneca (NYSE: AZN) today announced results from a 52-week Phase 3b
study in adults with type 2 diabetes who had inadequate glycemic control on
metformin therapy plus diet and exercise. This study found that the addition
of ONGLYZA(TM) (saxagliptin) 5 mg to existing [...]

Dapagliflozin As Add On Therapy To Insulin Demonstrated Improved Glycemic Control In Patients With Type 2 Diabetes Inadequately Controlled With Insulin

Not for US Media
ORLANDO, Florida, June 26, 2010 – Results from a 24-week Phase 3 clinical
study demonstrated that the addition of the investigational drug
dapagliflozin achieved reductions in the primary endpoint, glycosylated
hemoglobin level (HbA1c), in inadequately controlled type 2 diabetes patients
who were treated with insulin (with or without oral anti-diabetes medications
(OADs)), compared to placebo plus [...]

Merck Serono Calls for Entries to Real MS – Your Story, a Global Competition to Raise Awareness of Multiple Sclerosis

Campaign Website and Global Script Concept Competition Launch Today
GENEVA, June 25, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
today announces the start of the Real MS: Your Story competition, with the
campaign website (www.realmsvoices.com) now open for entry
submissions. Real MS: Your Story is the first element of Real MS, a global
multiple sclerosis [...]

Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union

CAMBRIDGE, Massachusetts, June 25, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announced today that the Committee for Medicinal
Products for Human Use (CHMP) of the European Medicines Agency adopted a
positive opinion on the marketing authorisation for VPRIV(TM) (velaglucerase
alfa), the company's enzyme replacement therapy (ERT) for the treatment of
type 1 Gaucher [...]

Serono Symposia International Foundation in Collaboration With ESHRE Announces Public Competition in Reproductive Medicine

ROME, June 29, 2010 – Serono Symposia International Foundation (SSIF), has announced
today a public competition for an award to recognise an expert in bioscience
who has made a significant contribution to medical education activities in
recent years. The ideal candidate has the potential to play a major role in
spreading science and has made outstanding contributions to [...]

Elsevier Announces New Access to Reaxys(R) To Raise Performance And Output For Chemists at Sapienza University of Rome

FRANKFURT, June 29, 2010 – Elsevier and Sapienza University of Rome today announced a new
agreement, providing researchers at the university with access to Reaxys
(www.info.reaxys.com/), Elsevier's workflow solution for research
chemists. Reflecting the way chemists think and work, Reaxys will enable
researchers at Sapienza to quickly find the chemistry relevant for their
needs and thereby raise their performance [...]

Disease and Therapy Review: Colorectal Cancer Now Available at ReportsandReports

DALLAS, June 29, 2010 – ReportsandReports announces it will carry the Disease and Therapy Review:
Colorectal Cancer Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-co
lorectal-cancer/
The Colorectal Cancer Disease and Therapy Review provides an overview of
the disease and related conditions, with incidence, prevalence and mortality
numbers and [...]

Disease and Therapy Review: Bladder Cancer Now Available at ReportsandReports

DALLAS, June 29, 2010 – ReportsandReports announces it will carry the Disease and Therapy Review:
Bladder Cancer Market Research Report in its Store

Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-bl
adder-cancer/
The Bladder Cancer Disease and Therapy Review provides an overview of the
disease and related conditions, with incidence, prevalence, and mortality
numbers and [...]

Disease and Therapy Review: Impetigo Now Available at ReportsandReports

ReportsandReports Announces it Will Carry the Disease and Therapy Review: Impetigo Market Research Report in its Store.

DALLAS, Texas, June 29, 2010 – Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-im
petigo/
The Impetigo Disease and Therapy Review provides an overview of the
disease, with incidence and prevalence estimates for major countries
worldwide Information on diagnosis, and an [...]

Disease and Therapy Review: Asthma Now Available at ReportsandReports

ReportsandReports Announces it Will Carry the Disease and Therapy Review: Asthma Market Research Report in its Store.

DALLAS, June 29, 2010 – Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-as
thma/
The Asthma Disease and Therapy Review provides an overview of the disease
and related conditions, with incidence and prevalence numbers and percentages
for major countries worldwide, information [...]

Disease and Therapy Review: Onychomycosis Now Available at ReportsandReports

DALLAS, June 29, 2010 – ReportsandReports announces it will carry the Disease and Therapy Review:
Onychomycosis Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-on
ychomycosis/
The Onychomycosis Disease and Therapy Review provides an overview of the
disease and subtypes, with incidence and prevalence numbers and percentages
for major countries [...]

Disease and Therapy Review: Ulcerative Colitis Now Available at ReportsandReports

DALLAS, June 29, 2010 – ReportsandReports announces it will carry the Disease and Therapy Review:
Ulcerative Colitis Market Research Report in its store.

Browse the complete Report on:
(www.reportsandreports.com/market-reports/disease-and-therapy-review-
ulcerative-colitis/)
The Ulcerative Colitis Disease and Therapy Review provides an overview of
the disease and related conditions, with incidence prevalence information for
major countries [...]

Cardio3 BioSciences Reports Positive Three-Month Data From its Clinical Trial of C-Cure(R) in Heart Failure

MONT-SAINT-GUIBERT, Belgium, June 29, 2010 – Cardio3 BioSciences, a leading Belgian biotechnology company specialising
in regenerative therapies for the treatment of cardiovascular diseases, today
announces positive safety data and preliminary efficacy results from its
clinical trial of C-Cure(R), a breakthrough stem cell therapy for heart
failure.

Results showed C-Cure to have a very good safety [...]

Assist America Announces Formation of Assist America Middle East

PRINCETON, New Jersey, June 29, 2010 – Assist America announced today the formation of Assist America Middle
East and North Africa (AAME), to be headquartered in Beirut, Lebanon. AAME
will serve as the exclusive marketing arm for Assist America in the Middle
East and North Africa. The company's focus is to expand Assist America's
global emergency services in [...]